Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NW Low-Glu vs Metformin in Type 2 Diabetes
NCT06140485Phase 3Not yet recruiting
- Sponsor
- Natural Wellness
- Start
- Mar 2024
- Primary completion
- Sep 2025
01
Overview
Phase 3, randomised, double-blind trial (2 arms), sponsored by Natural Wellness. Primary endpoint: Mean change in HbA1c levels at 6 months. Planned start Mar 2024; status: not yet recruiting.
Beyond the preview
Go deeper on NCT06140485.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06140485.